News

Manel Esteller, Josep Baselga and Joan Massagué receive the XXVIII Catalonia International Prize from President Puigdemont

Yesterday night, the President of the Generalitat de Catalunya (Catalan Government), Carles Puigdemont, awarded oncologists Manel Esteller, Joan Massagué and Josep Baselga the28th Catalunya International Prize“for his revolutionary task, especially on oncology research, with what they significantly contributed to the advances of global medicine”. These awards are given every year to people who contributed with […]

Leer más about Manel Esteller, Josep Baselga and Joan Massagué receive the XXVIII Catalonia International Prize from President Puigdemont

Grupo Témporing supports IDIBELL’s research on ELA

IDIBELL and the Temporing Group Company, headquartered in Barcelona, have reached a sponsorship agreement to boost funding for research on amyotrophic lateral sclerosis (ALS). Temporing is one of the temporary employment agencies most prestigious in the Spanish market, backed by fifteen years of experience, and integrate more than one hundred forty professionals in human resources. […]

Leer más about Grupo Témporing supports IDIBELL’s research on ELA

Identified a key protein in the generation of B lymphocytes

Hematopoietic System Repression of “inappropriate” genes Article’s reference

Leer más about Identified a key protein in the generation of B lymphocytes

Researchers identify a key molecule in psoriasis development

A study published in Journal of Investigative Dermatology has identified a potential therapeutic target for the treatment of psoriasis, a chronic inflammatory disease of the skin that affects up to a 2% of the population and which has still no cure. The study shows that the TREX2 gene has a relevant role in the inflammatory […]

Leer más about Researchers identify a key molecule in psoriasis development

The XII Mediterranean Marathon will run to overcome autoimmune diseases

On October 12th, the Mediterranean Marathon, one of the consolidated sports programming dating in the country, reaches its XII edition. Under the slogan “Do not run, fly!” participants in the race can make, voluntarily and for the first time in the history of this competition, a charitable contribution to a research project of the Bellvitge […]

Leer más about The XII Mediterranean Marathon will run to overcome autoimmune diseases

IDIBELL presents its technology portfolio in Biospain 2016

From today until next Friday, the business development & innovation area of IDIBELL will participate in the eighth edition of Biospain 2016 , the most important biotech event in southern Europe

Leer más about IDIBELL presents its technology portfolio in Biospain 2016

When learning is fun – scientists prove how the brain simulates external rewards to boost memory formation

Humans can learn effectively, especially when they are externally rewarded (for example, with money or desirable incentives after their actions). Instead of externally-triggered learning (carrot-based learning), self-organised or intrinsically driven learning refers to those learning processes without any objective reward. If you think of it, humans are often involved in these types of rewardless learning […]

Leer más about When learning is fun – scientists prove how the brain simulates external rewards to boost memory formation

Scientists find mutations associated with unusual forms of Rett syndrome

An article published in the journal Human Genetics by Manel Esteller, Director of the Program for Epigenetics and Cancer Biology (PEBC) of Bellvitge Biomedical Research Institute (IDIBELL), ICREA researcher and Professor of Genetics of the University of Barcelona, ​​discovers mutations in genes associated with the development of atypical Rett syndrome, and distinguishes this clinical entity […]

Leer más about Scientists find mutations associated with unusual forms of Rett syndrome

ONCE and IDIBELL working together in a Project on Retinitis Pigmentosa

The research deals with functional studies of genes linked to a type of inherited blindness in order to identify potential therapeutic targets

Leer más about ONCE and IDIBELL working together in a Project on Retinitis Pigmentosa
Scroll to Top